# OLANZAPINE
> **ANDA220323** · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2026-03-05
## Drug
- **FDA Application Number:** ANDA220323
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** ANTHEA PHARMA
- **Manufacturer:** GLENMARK PHARMACEUTICALS INC., USA
- **First approval:** 2026-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220323)
---
*AI Analytics · CC0 1.0*